Dec 21, 2015
Board of Directors
• MBA, FCA
• Chartered accountant: PWC
• Management consultancy:
Reed Cons.
Managing and Financial DirectorJuliane Klein
• MBA Business and Marketing gExeter University
• 5 years Marketing at Unilever gLondon
• MD University of Sao Paulo, MBA gHarvard University
• 8 years Head of Department of Clinical gScience
• PhD in Human Physiology gNewcastle University
• 6 years postdoctoral experience
R&D DirectorMatthew Wilcox
Marketing DirectorLaura Pascoe
Operations DirectorAlessandra S. Dantas
Research and Development
•Tablet that you take before your main meal
•Forms a gel in the stomach•Gives the feeling fullness•Weight loss•Reduction in bile re-uptake•Therefore lowers cholesterol
Intellectual Property Time Line
20062005 20082007
University File Patent
University File for PCT
Prosecute in US, Canada, Europe, Japan, China and India
UK Patent Granted
Pipe Line•Product Line
▫Different Vehicles for Administration▫Different Flavours▫Different Doses
•Product Range▫Diabetes prevention and control ▫Specific cholesterol lowering▫Inhibition of Dietary Enzymes
Overview, Drivers & CompetitionOverweight individuals UK
Men
Women
Currently trying to lose weight
MenWomen
Source: 200 16+ males and females interviewed Newcastle and London
• Food and supplement market £75 billion in Europe
1
1-3
4-7
8
Timeline and Milestones for Production of 1 million sample packets of
Accelerol®Buy in & shipment of raw material for WeightWatchers trial
Stock piling and initial distribution to Boots, intensive advertising
Mon
ths
Accelerol® pressing and distribution to WeightWatchers trial
Accelerol ® available to purchase from Boots nationwide
Your InvestmentPersonal investment: £20,000/Director
2008 20102007
Company set up (Ltd.) and University buy out: £80,000 (pref. shares) + 10% company
Company Equity Share
£80,000 for patent applications in Europe, USA, Canada, Japan, China, India
Possible exit through IPO or Trade Sale
Start of product trial through health clubs, Quality assurance
Start of large scale production and product launch UK
Initial Investment:
£800,000 for 40% equity
2011
Closing negotiations for whole sale to Danone, Unilever, Nestle
2009
BBSRC Entrepreneur Fellowship
1NE Research and Development Grant £100,000
2012 2013
22.5%
22.5%
22.5%
22.5%10%
Financial Projections
Production cost/unit: £0.50
Unit price whole sale: £2.50
Company value after 5 years: £31 M
Year 1 Year 2 Year 3 Year 4 Year 5
£795.000
£7.7M £12.6M £17.5M £28.5M